Conmed (CNMD) Misses Q4 EPS by 5c, offers guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/18/2026

1. SPY
2. EYPT
3. AWK
4. TSLA
5. NVDA
6. USO
7. GNK
8. ARGX
9. PLUR
10. MU

January 31, 2024 4:07 PM EST

Conmed (NYSE: CNMD) reported Q4 EPS of $1.06, $0.05 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $327 million versus the consensus estimate of $332.22 million.

GUIDANCE:

Conmed sees FY2024 EPS of $4.30-$4.40, versus the consensus of $4.40. Conmed sees FY2024 revenue of $1.34-1.365 billion, versus the consensus of $1.357 billion.

For earnings history and earnings-related data on Conmed (CNMD) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance

Related Entities

Earnings